CAR T-cells: costs, comparisons, and commentary

J Med Econ. 2019 Jul;22(7):613-615. doi: 10.1080/13696998.2019.1582059. Epub 2019 Mar 21.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cost-Benefit Analysis
  • Humans
  • Lymphoma, B-Cell*
  • T-Lymphocytes
  • United States